期刊文献+

西宁地区库存血HCV RNA、HIV RNA核酸扩增技术(NAT)的检测与分析

Detection and Analysis of HCV, HIV in the Collected Blood
原文传递
导出
摘要 目的 :调查库存血感染HCV、HIV的危险度 ,正确评估西宁地区目前酶免抗体筛检方法的血液安全性。方法 :使用ProcleixTM TMAHIV - 1 /HCV检测方法对 1 0 0 86份库存血进行检测。结果 :发现 3份NAT检测HCVRNA和EIISA检测抗 -HCV均阳性的标本 ,未发现NAT检测阳性 ,但EIA检测抗 -HCV、抗 -HIV阴性的标本。未发现血清抗体转换窗口期标本。结论 :西宁地区目前HCV、HIV的感染危险度小于 1 1 0 0 0 0 ,说明本地区目前血液检测质量是可信的 。 Objective: To investigate whether there is a risk of HCV and HIV infection in the collected blood and assay the effect of ELISA on the security of transfusion in Xining. Method: A total of 10086 samples were examined with ProcleixTM TMA and ELISA to detect the infective risk of HIV and HCV. Result: 3 samples were HCV positive both in Nucleic acid Amplification Test (NAT) and ELISA method. No positive HCV or HIV was in NAT but negative in ELISA. No case in window period was detected. Conclusion: The risk rate of HCV and HIV infection in collected blood are lower than 1/10 000. The quality of blood is better,in Xining, so transfusion is more safety for the patients.
作者 贾嫈
机构地区 青海省血液中心
出处 《高原医学杂志》 CAS 2004年第2期28-31,共4页 Journal of High Altitude Medicine
基金 20 0 0年省科委立项课题 项目基金号 2 0 0 0 -N -5 0 4
关键词 输血 核酸扩增技术 HCV HIV Transfusion, NAT(Nucleic acid Amplification Test) HCV HIV
  • 相关文献

参考文献9

  • 1Schreiber GB. Bush MP. Kleinman SH,et al. The risk of donors study. N Engl J Med,1996,334:1 685.
  • 2Gallarda JL,Dragon E.Blood screening by nucleic acid amplification technology:current issues,future challenges.Mol Diagn,2000,5(1):11.
  • 3Kozal MJ, Shah N,Shen N, et al. Extensive Polymophisms observed in HIV clade B protease gene using high-density oligonucleotide arrays.[J] Nature Medicine, 1996,2(7):253.
  • 4Stramer SL. US NAT yield: where are we after 2 years? Transfusion Clinique et Biologique,2003,10(1):10.
  • 5Chiron Blood Testing. Chiron TMA HIV-1/HCV assay training manual 2000, Chapter 3:1-33.
  • 6Noel L. GAT testing:added value In:Smit Sibinga C Th,Alters HJ.Risk management in blood transfusion:The virtue of reality.Dordrecht,Kluwer Academic Publishers,1999,109-117.
  • 7Assal A, Coste J,Barlet, et al. Application de la biologie moléculaire à la sécurité virale transfusionnelle : le dépistage génomique viral. Transfusion Clinique et Biologique,2003,10(3):217.
  • 8雷永良,纪勇平,吴丽雅.抗-HCV ELISA检测阴性献血者HCV-RNA流行率调查[J].中国输血杂志,2002,15(4):264-265. 被引量:32
  • 9王迅,郑岚,张晰,凌冰,许莉萍,黄宇闻,陆萍,莫琴,韩永年,高峰.核酸扩增技术在上海血液筛检中的初步应用[J].中国输血杂志,2003,16(3):157-160. 被引量:69

二级参考文献8

  • 1Chiton Blood Testing. Chiton TMA HIV-1/HCV assay training manual 2000,Chapter 3: 1-- 33.
  • 2Bruisten SM,Oudshoorn P,van Swieten P,et al. Stability of HIV-1 RNA in blood during specimen handing and storage prior to amplification by NASBA-QT. J Virol Meth, 1997,67:199.
  • 3Schreiber GB, Bush MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infection. The Retrovirus Epidemiology Donors Study. N Engl J Med, 1996,334:1685.
  • 4Gallarda JL,Dragon E. Blood screening by nucleic acid amplification technology: current issues, furore challenges. Mol Diag,2000,5:11.
  • 5Noeel, L. GAT testing:added value. In:Smit Sibinga C Th, Alters HJ,eds. Risk management in blood transfusion:The virtue of reality. Dordrecht, Kluwer Academic Publishers, 1999:109-117.
  • 6Murthy KK,Henrard DR,Eichberg JW,et al. Redifining the HIV-infectious window period in chimpanzee model: Evidence to suggest that viral nucleic acld testing can prevent blood-home transmission. Transfusion, 1999,39: 688.
  • 7赵国胜,黄鹏,周庆申,孙丽君,王军,周剑英,何焰.湖北地区抗-HCV阴性献血者丙型肝炎病毒核酸流行率研究(1993年~2000年)[J].国外医学(输血及血液学分册),2001,24(2):162-164. 被引量:13
  • 8高峰,张晰,王迅,韩永年,夏孝勋,余国定.血液病毒标志物两次检测模式的探讨[J].中国输血杂志,2001,14(4):205-208. 被引量:45

共引文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部